"In our study, we showed that fine needle aspiration (FNA) biopsy material can be a good source for next-generation sequencing (NGS) for patients with metastatic prostate cancer. Based on these ...
Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma Human epidermal growth factor 2 (HER2/ERBB2) has ...
Discover the latest advancements in pancreatic cancer treatment, including targeted therapies and next-generation sequencing, transforming patient care and outcomes.
Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
A recent study reveals significant progress in biomarker testing for lung cancer in community settings, highlighting the need ...
Medical Device Network on MSN
Quest launches flow cytometry MRD test for myeloma
Quest expects the new blood test will support response monitoring in clinical trials.
New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.
ABP News on MSN
World Cancer Day 2026: How Precision Onco-Haematology Is Personalising Blood Cancer Treatment And Reducing Relapse
By: Dr. Amrit Kaur Kaler For patients diagnosed with blood cancers such as leukemia, lymphoma, and multiple myeloma, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results